HILS
Price:
$0.237
Market Cap:
$4.17M
Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that initiates iron-mediated cell death (IMCD), specifically to address cancers that are resistant to conventional treatments. The company's developmental pipeline features several key candidates: HSB-1216: An IMCD inducer currently under development for solid tumor indications. HSB-888: An IMCD inducer incorporating an anthracycline analogue, delivered via a dual Quatramer system, also aimed at solid tumors. HSB-510: A targeted bifunctional inhibitory compound, encapsulated within the Quatramer deli...[Read more]
Industry
Biotechnology
IPO Date
2022-01-12
Stock Exchange
NASDAQ
Ticker
HILS
According to Hillstream BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.34. This represents a change of 289.95% compared to the average of -0.09 of the last 4 quarters.
The mean historical PE Ratio of Hillstream BioPharma, Inc. over the last ten years is -9.10. The current -0.34 PE Ratio has changed 272.07% with respect to the historical average. Over the past ten years (40 quarters), HILS's PE Ratio was at its highest in in the December 2021 quarter at 3.63. The PE Ratio was at its lowest in in the September 2020 quarter at -27.62.
Average
-9.10
Median
-0.52
Minimum
-34.80
Maximum
-0.02
Discovering the peaks and valleys of Hillstream BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 740.18%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -95.52%
Minimum Annual PE Ratio = -34.80
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.16 | 740.18% |
| 2024 | -0.02 | -24.12% |
| 2023 | -0.03 | -95.12% |
| 2022 | -0.52 | -95.52% |
| 2021 | -11.60 | -30.00% |
| 2020 | -16.57 | -52.38% |
The current PE Ratio of Hillstream BioPharma, Inc. (HILS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.07
5-year avg
-2.47
10-year avg
-9.10
Hillstream BioPharma, Inc.’s PE Ratio is less than TNF Pharmaceuticals, Inc. (-0.19), less than Gamida Cell Ltd. (-0.08), less than Aptose Biosciences Inc. (-0.16), less than Gritstone bio, Inc. (-0.03), less than Altamira Therapeutics Ltd. (-0.02), greater than VivoSim Labs, Inc. (-1.31), less than Nabriva Therapeutics plc (-0.00), less than Atreca, Inc. (-0.04), less than Onconetix, Inc. (-0.11), less than Unity Biotechnology, Inc. (-0.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.19 | $9.18M | |
| -0.08 | $4.34M | |
| -0.16 | $4.36M | |
| -0.03 | $3.80M | |
| -0.02 | $1.13M | |
| -1.31 | $2.87M | |
| -0.00 | $323.00 | |
| -0.04 | $3.57M | |
| -0.11 | $315.29K | |
| -0.21 | $3.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hillstream BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hillstream BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hillstream BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hillstream BioPharma, Inc. (HILS)?
What is the highest PE Ratio for Hillstream BioPharma, Inc. (HILS)?
What is the 3-year average PE Ratio for Hillstream BioPharma, Inc. (HILS)?
What is the 5-year average PE Ratio for Hillstream BioPharma, Inc. (HILS)?
How does the current PE Ratio for Hillstream BioPharma, Inc. (HILS) compare to its historical average?